Cargando…

Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases

Detalles Bibliográficos
Autores principales:	Li, Feng, Wang, Shaogui, Chao, Xiaojuan, Wang, Shuai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846081/ https://www.ncbi.nlm.nih.gov/pubmed/36686699 http://dx.doi.org/10.3389/fphar.2022.1121821

Ejemplares similares

Editorial: Development of novel small molecules as therapeutics for inflammatory diseases and delineating their molecular mechanisms
por: Ramprasath, Tharmarajan, et al.
Publicado: (2022)

Editorial: Novel small molecules in targeted cancer therapy
por: Li, Rong, et al.
Publicado: (2023)

Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases
por: Shao, Zhuo, et al.
Publicado: (2021)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
por: Shi, Zhi, et al.
Publicado: (2022)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Editorial: Metal-complexed molecules of natural and synthetic origin: Pharmacological advances and therapeutic applications
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases
por: Liang, Yongyi, et al.
Publicado: (2023)

Editorial: Recent Advances in Cardiotoxicity Testing
por: Mohamed, Tamer M. A., et al.
Publicado: (2021)

Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets
por: Blas-García, Ana, et al.
Publicado: (2022)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017)

Editorial: IBD Management—Novel Targets and Therapeutic Perspectives
por: Antonioli, Luca, et al.
Publicado: (2020)

Editorial: Natural products in the treatment of neurological diseases: identification of novel active compounds and therapeutic targets
por: Zhao, Jia, et al.
Publicado: (2023)

Editorial: Recent advances in radiation medical countermeasures
por: Tichy, Ales, et al.
Publicado: (2022)

Recent Advances in Nano-Therapeutic Strategies for Osteoarthritis
por: Guo, Xinjing, et al.
Publicado: (2022)

Editorial: Novel therapeutic approaches to target drug resistant tumors
por: Riganti, Chiara, et al.
Publicado: (2023)

Editorial: Therapeutic Advances in Melatonin Research
por: López-Muñoz, Francisco, et al.
Publicado: (2022)

Editorial: Recent Advances in Voltage-Gated Sodium Channels, their Pharmacology and Related Diseases
por: Chahine, Mohamed, et al.
Publicado: (2016)

Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
por: Mokry, Juraj, et al.
Publicado: (2021)

Editorial: Biomedical advances in ultrasound-mediated drug/molecule delivery
por: Exner, Agata A., et al.
Publicado: (2022)

Editorial: Targeted cancer therapies, from small molecules to antibodies, volume II
por: Su, Chao-Yue, et al.
Publicado: (2023)

Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies
por: Hua, Susan
Publicado: (2013)

Recent advances in the development of RIPK2 modulators for the treatment of inflammatory diseases
por: Pham, Anh-Tuan, et al.
Publicado: (2023)

Editorial: New therapeutic targets for human placental angiogenesis disease
por: Escudero, Carlos A.
Publicado: (2014)

Editorial: Platelets in Disease: From Biomarkers Discovery to Therapeutic Targets
por: Zhao, Fan, et al.
Publicado: (2022)

Editorial: New Advances in RNA Targeting
por: Ilinskaya, Olga, et al.
Publicado: (2020)

Editorial: Advances on targeted nanomedicines for atherosclerosis
por: Han, Qinggong, et al.
Publicado: (2022)

Editorial: Recent trends and spotlight on nucleotide-based drugs: novel targets, their design, delivery, and clinical potential
por: Chander, Subhash, et al.
Publicado: (2023)

Editorial: Novel Targets and the Application of Targeting Techniques in the Treatment of Cerebrovascular Disease
por: Liu, Zhidong, et al.
Publicado: (2019)

Editorial: Advances in drug-induced diseases
por: Liu, Yao, et al.
Publicado: (2023)

Editorial: Therapeutic targeting of splicing variants in cancer
por: Sarvari, Pouya, et al.
Publicado: (2023)

Editorial: Novel Therapeutic Interventions Against Infectious Diseases: COVID-19
por: Sakkiah, Sugunadevi, et al.
Publicado: (2022)

Editorial: Novel therapeutic approaches for the treatment of ocular disease, Volume II
por: Thermos, Kyriaki, et al.
Publicado: (2022)

Editorial: Advances in inflammatory bowel disease: Mucosal defense mechanisms against gut inflammation
por: Corr, Sinéad C., et al.
Publicado: (2023)

Editorial: Novel modalities in cancer diagnostics and therapeutics
por: Zhao, Serena Li, et al.
Publicado: (2022)

Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
por: Ribeiro, Carla Maria Pedrosa, et al.
Publicado: (2021)

Editorial: Novel pharmacological approaches targeting mitochondrial dysfunction in diseases
por: Uddin, Md. Jamal, et al.
Publicado: (2022)

Editorial: Cancer of gastrointestinal tract: Novel insight into the molecular mechanisms related to inflammation and therapeutic targets
por: Banerjee, Aditi, et al.
Publicado: (2022)

Editorial: Big data for biomedical research of inflammatory diseases
por: Mao, Jingxin, et al.
Publicado: (2023)

Editorial: Role of Nrf2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches
por: Egea, Javier, et al.
Publicado: (2019)

Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
por: Zhang, Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ftn4qukf8u0et3n2pq7r5eqvur